Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Fallopian Tube Serous Adenocarcinoma

Clinical trial condition

Recurrent Fallopian Tube Serous Adenocarcinoma

Explore clinical trials studying Recurrent Fallopian Tube Serous Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Recurrent Fallopian Tube Serous Adenocarcinoma trial results

Recruiting

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

NCT05231122

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +29 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details